Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression

Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis

(2014) F Kastelein et al.   GUT

Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study

(2014) Shivaram K Bhat et al.   GUT

Impact of Endoscopic Surveillance on Mortality From Barrett's Esophagus–Associated Esophageal Adenocarcinomas

(2013) Douglas A. Corley et al.   GASTROENTEROLOGY

Long-term Efficacy and Safety of Endoscopic Resection for Patients With Mucosal Adenocarcinoma of the Esophagus

(2013) Oliver Pech et al.   GASTROENTEROLOGY

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

(2013) Rebecca C Fitzgerald et al.   GUT

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma

(2013) Kimberly S. Grant et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus

(2012) Florine Kastelein et al.   Clinical Gastroenterology and Hepatology

Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

(2012) Florine Kastelein et al.   GUT

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of Acid Suppression in the Development and Progression of Dysplasia in Patients with Barrett’s Esophagus

(2011) F. Kastelein et al.   DIGESTIVE DISEASES

Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009

(2011) Marjolein Y.V. Homs et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus

(2011) Florine Kastelein et al.   GASTROENTEROLOGY

The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis

(2011) Tusar K Desai et al.   GUT

Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study

(2011) S. Bhat et al.   JNCI-Journal of the National Cancer Institute

Incidence of Adenocarcinoma among Patients with Barrett's Esophagus

(2011) Frederik Hvid-Jensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy

(2010) Devidas Menon et al.   BMC GASTROENTEROLOGY

Long-term survival and cost analysis of an annual Barrettʼs surveillance programme

(2010) Keith J. Roberts et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study

(2010) P. J. F. de Jonge et al.   GUT

Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population-Based Study With Temporal Trends

(2009) Gregory S Cooper et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis

(2009) Marjolein Sikkema et al.   Clinical Gastroenterology and Hepatology

Systematic Four-Quadrant Biopsy Detects Barrett's Dysplasia in More Patients Than Nonsystematic Biopsy

(2008) Jo-Etienne Abela et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

(2008) Kenneth K. Wang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY